什么是类风湿性因素? 从查到个性化管理
1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Rheumatology (Oxford, England)
|January 10, 2025
概括
类风湿性因素 (RF) 自抗体可以降低类风湿性关节炎 (RA) 患者的治疗效果. 塞尔科利祖马布佩戈尔 (CZP) 是一种缺乏Fc区域的TNF抑制剂,在高射频水平的患者中显示持续有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类风湿性因素 (RF) 是常见于类风湿性关节炎 (RA) 患者的自身抗体.
- 高射频水平与RA严重程度,关节损伤和较差的治疗结果相关.
- 目前的治疗指南缺乏根据RF状态选择TNF抑制剂的具体建议.
研究的目的:
- 评估高类风湿因子 (RF) 水平对TNF抑制剂在类风湿性关节炎 (RA) 治疗中的疗效的影响.
- 调查Certolizumab pegol (CZP) 的潜在益处,Certolizumab pegol (CZP) 是一种没有Fc区域的TNF抑制剂,在高RF水平的患者中.
主要方法:
- 在不同RF水平的RA患者中对TNF抑制剂疗效的比较分析.
- 在患有高血清RF的患者中对CZP的药理动力学评估.
- 在体外研究检查了含Fc的生物药物和RF之间的相互作用.
主要成果:
- 高血清射频水平与某些TNF抑制剂的反应和保留率降低有关.
- 塞尔科利祖马布佩戈尔 (CZP) 维持高血度和高射频水平的RA患者的疗效.
- 具有Fc区域的抗体药物在结合高水平的IgM-RF时容易降解.
结论:
- 缺少Fc区域的 Certolizumab pegol (CZP) 可能是具有高类风湿因子 (RF) 水平的RA患者更有利的治疗选择.
- 抗体药物的Fc区域有助于它们在高射频的情况下降低有效性.
- 需要进行进一步的研究,以制定RF阳性RA患者Fc区域含有生物制剂的指导方针.
相关概念视频
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Rh Blood Group
1.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.3K


